Showing 1 to 10 of 21
Title | Reference number | Reference number sort | Published | Published date sort | Last updated | Last updated sort |
---|---|---|---|---|---|---|
COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Reference number:NG188 | NG00188 | Published:18 December 2020 | 20201218 | Last updated:18 December 2020 | 20201218 |
COVID-19 rapid guideline: vitamin D | Reference number:NG187 | NG00187 | Published:17 December 2020 | 20201217 | Last updated:17 December 2020 | 20201217 |
Atezolizumab with bevacizumab for treating advanced or unresectable hepatocellular carcinoma | Reference number:TA666 | TA00666 | Published:16 December 2020 | 20201216 | Last updated:16 December 2020 | 20201216 |
Caplacizumab with plasma exchange and immunosuppression for treating acute acquired thrombotic thrombocytopenic purpura | Reference number:TA667 | TA00667 | Published:16 December 2020 | 20201216 | Last updated:16 December 2020 | 20201216 |
Pancreatitis | Reference number:NG104 | NG00104 | Published:05 September 2018 | 20180905 | Last updated:16 December 2020 | 20201216 |
Eating disorders: recognition and treatment | Reference number:NG69 | NG00069 | Published:23 May 2017 | 20170523 | Last updated:16 December 2020 | 20201216 |
Type 2 diabetes in adults: management | Reference number:NG28 | NG00028 | Published:02 December 2015 | 20151202 | Last updated:16 December 2020 | 20201216 |
Type 1 diabetes in adults: diagnosis and management | Reference number:NG17 | NG00017 | Published:26 August 2015 | 20150826 | Last updated:16 December 2020 | 20201216 |
Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Reference number:NG18 | NG00018 | Published:01 August 2015 | 20150801 | Last updated:16 December 2020 | 20201216 |
Diabetes in pregnancy: management from preconception to the postnatal period | Reference number:NG3 | NG00003 | Published:25 February 2015 | 20150225 | Last updated:16 December 2020 | 20201216 |